Abstract
Objective
Treatment modality for ruptured and unruptured intracranial aneurysms has shifted during the last two decades from microsurgical treatment towards endovascular treatment. We present how this transition happened in a large European neurovascular center.
Methods
We conducted a retrospective observational study consecutive patients treated for an unruptured or ruptured intracranial aneurysm at Helsinki University Hospital during 2012–2022. We used Poisson regression analysis to report age-adjusted treatment trends by aneurysm location and rupture status.
Results
A total of 2491 patients with intracranial aneurysms were treated (44% ruptured, 56% unruptured): 1421 (57%) surgically and 1070 (43%) endovascularly. A general trend towards fewer treated aneurysms was noted. The proportion of patients treated surgically decreased from 90% in 2012 to 20% in 2022. The age-adjusted decrease of surgical versus endovascular treatment was 6.9%/year for all aneurysms, 6.8% for ruptured aneurysms, and 6.8% for unruptured aneurysms. The decrease of surgical treatment was most evident in unruptured vertebrobasilar aneurysms (10.8%/year), unruptured communicating artery aneurysms (10.1%/year), ruptured communicating artery aneurysms (10.0%/year), and ruptured internal carotid aneurysms (9.0%/year). There was no change in treatment modality for middle cerebral artery aneurysms, of which 85% were still surgically treated in 2022. A trend towards an increasing size for treated ruptured aneurysms was found (p = 0.033).
Conclusion
A significant shift of the treatment modality from surgical to endovascular treatment occurred for all aneurysm locations except for middle cerebral artery aneurysms. Whether this shift has affected long-term safety and patient outcomes should be assessed in the future.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
The prevalence of unruptured intracranial unruptured aneurysms is reported to be as high as 6.6% in the general population [15]. However, only a minority of unruptured aneurysms will rupture and cause subarachnoid hemorrhage (SAH), the SAH incidence being approximately 6 per 100,000 [10]. Following SAH, 24% of the affected die outside of the hospital wards (e.g., at home, in ambulances, or in emergency rooms) and overall 39% die within 1 month of SAH [3]. With only a few natural history studies on unruptured aneurysms [14, 21, 49], decisions about prophylactic treatment are based on aneurysm-specific characteristics such as aneurysm location, size, morphology, and specific patient characteristics such as age, smoking status, and comorbidities [11].
Surgical treatment of intracranial aneurysms was first described almost 100 years ago [8] and remained the first-line choice for both the treatment of ruptured and unruptured intracranial aneurysms until 2002, when the ISAT trial reported more favorable functional outcomes following endovascular versus surgical treatment for ruptured intracranial aneurysms [26]. The trial results—that showed improved functional outcomes in good grade (World Federation of Neurosurgical Societies grade I–III) SAH after endovascular versus surgical treatment from an internal carotid (ICA) or posterior circulation aneurysm—were heavily extrapolated to include all intracranial aneurysms, independent of location, rupture status, or used endovascular technique [2]. While there is a paucity in the level of evidence supporting the shift from surgical to endovascular treatment, the shift has continued [37]. The transition towards endovascular treatment has happened at different paces depending on the local traditions and circumstances. Nowadays, endovascular treatment is the dominant treatment modality for intracranial aneurysms in developed countries. The same trend has happened in the invasive treatment of coronary disease where angioplasties and stents have replaced bypasses in the majority of patients [9, 50].
In this study, we analyzed the transition period from microsurgical to endovascular treatment in one high volume European neurovascular center. We aimed to explore how different aneurysm locations, aneurysm size, and rupture status affected the shift of treatment modalities.
Methods
Study setting and patient population
We conducted an observational retrospective study including all consecutive patients treated for unruptured or ruptured saccular intracranial aneurysms at Helsinki University Hospital (Helsinki, Finland) from January 2012 to December 2022. Helsinki University Hospital is the only neurosurgical unit covering a population of approximately 2.2 million people in Southern Finland (40% of the total population in Finland). It is the largest university hospital in the country and one of the largest hospitals in Europe with a well-known neurovascular practice.
We screened the electronical hospital records for all patients who were treated for either a ruptured or an unruptured intracranial aneurysm during the study period. We manually reviewed all cases and excluded the patients with aneurysms related to arteriovenous malformations, dural arteriovenous fistulas, or moyamoya disease. We only included patients whose aneurysm was treated.
The study was approved by the local research board and conducted according to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) recommendations [47].
Data collection
We extracted the data from electronic healthcare records and the picture archiving communication system. We recorded patient age at the time of treatment, sex, date, and modality of treatment (i.e., surgical versus endovascular), whether multiple aneurysms were treated in the same session, location of aneurysm(s), maximum size of the aneurysm(s), and aneurysm rupture status. We defined aneurysm maximum size as the largest diameter. For surgically treated patients, we measured the maximum diameter from the preoperative CT angiography because surgically treated patients rarely undergo digital subtraction angiography (DSA) in our institution. For endovascularly treated patients, we measured the maximum diameter from the projectional 2D DSA images and in case of a large partly thrombosed aneurysm, the maximum diameter was measured from pre-interventional CT angiography or MR images.
We classified endovascular treatment into coiling (including stent-assisted coiling and balloon-assisted coiling), intrasaccular device, flow diversion, and parent artery occlusion. We classified surgical treatment into clipping, proximal artery ligation, trapping, wrapping, or bypass. Due to the low number of patients undergoing proximal artery ligation, trapping, and wrapping, and their surgical similarities, these procedures were grouped for the analyses. We categorized intracranial aneurysm location into ICA, anterior communicating artery + A1 segment of the anterior cerebral artery (ACOM + A1), pericallosal artery, M1 segment of the middle cerebral artery (M1), middle cerebral artery (MCA) bifurcation or distal MCA (MCA-bif + distal MCA), vertebral artery + basilar artery + posterior cerebral artery (VBA + PCA), and posterior inferior cerebellar artery + anterior inferior cerebellar artery + superior cerebellar artery (PICA + AICA + SCA).
Statistical methods
We presented categorical data as numbers with percentages, normally distributed data as means with standard deviations (SD) and non-parametric data as medians with interquartile range (IQR). Due to the large sample size and inherited group disparities, we did not test for significance levels between groups for baseline characteristics.
We calculated the annual change in treatment modality (surgery vs. endovascular) using marginal effects after fitting a Poisson regression model adjusting for patient age, checking for overdispersion. For the Poisson regression analyses, statistical significance was considered if the 95% confidence interval (CI) did not overlap 0.0. We used a Jonckheere-Terpstra test to test for trends in aneurysm size during the study period.
Results
Patient population
From January 2012 to December 2022, a total of 2491 patients with intracranial aneurysms were treated. Of these, 1421 patients (57%) were treated surgically and 1070 patients (43%) endovascularly. The median age was 58 years (IQR 49–65), 65% were women, maximum aneurysm size was 6 mm (IQR 4–8), and 44% were treated for a ruptured aneurysm (Table 1). Age and sex distributions were similar between the surgically and endovascularly treated patients. More patients in the endovascular group versus surgical group were treated for a ruptured aneurysm (53% vs. 37%). The most common aneurysm locations for surgically treated patients were MCA-bif or distal MCA (53%), ACOM + A1 (15%), and ICA (13%). The most common aneurysm locations for endovascularly treated patients were ACOM + A1 (36%), ICA (34%), and VBA + PCA (16%).
Clip ligation (97%) was by far the most common surgical treatment technique. Coiling (73%) followed by flow diversion (16%) and intrasaccular device (10%) were the most employed endovascular techniques. Patient and aneurysm characteristics for the different surgical and endovascular treatments are displayed in eTable 1 and 2.
Overall unadjusted treatment trends
There was a general decreasing trend in the number of aneurysms treated from 2012 to 2022 (decrease with 7 aneurysms per year, 95% CI 4 to 10, Fig. 1). In 2012, only 10% of all aneurysms were treated endovascularly, after 2017 over 50%, and at the end of 2022 almost 80% of all aneurysms, respectively (eFigure 1). A rapid shift from surgical to endovascular treatment of posterior circulation and anterior circulating aneurysms (excluding all MCA aneurysms) occurred after 2014, whereas surgical treatment has remained the dominating modality for MCA aneurysms (eFigure 1). The median size for clipped aneurysms was somewhat larger than the median size for endovascularly treated aneurysms (eFigure 2). Regarding endovascular treatment modality, the use of flow diverters increased drastically for unruptured ICA aneurysms from 2018 onward (eFigure 3).
Unadjusted treatment trends for ruptured and unruptured aneurysms by location
We observed a clear shift from surgical to endovascular treatment for all other locations except for MCA aneurysms occurred during the study period (Fig. 2). For all locations where the treatment modality changed, it happened first for the ruptured aneurysms followed later by the unruptured aneurysms. Although the general trend showed a decrease in the number of treated aneurysms, surgical treatment for ruptured MCA aneurysms and endovascular treatment for ruptured and unruptured ACOM + A1 and ICA aneurysms remained stable (eFigure 4). There was a trend towards larger sizes for ruptured but not unruptured aneurysms (p for trend = 0.003 and 0.078, respectively) (eFigure 5).
Poisson regression
Age-adjusted trends confirmed the results of the unadjusted analysis. Regarding all aneurysms (ruptured and unruptured), the total annual rate of surgical treatment decreased by 6.9% compared to endovascular treatment. The decrease was most evident in unruptured VBA + PCA aneurysms (10.8%/year), unruptured ACOM + A1 aneurysms (10.1%/year), ruptured ACOM + A1 aneurysms (10.0%/year), and ruptured ICA aneurysms (9.0%/year). There was no change for MCA aneurysms (M1, MCA-bif + M2 distal). Due to the relatively low sample size, no statistically significant change was noted when separately analyzing ruptured and unruptured PICA + AICA + SCA (ruptured n = 62, unruptured n = 30) and pericallosal aneurysm (ruptured n = 33, unruptured n = 69), although the change was significant when combining unruptured and ruptured aneurysms in the same locations. Still, the confidence estimates suggest a strong trend towards a shift from surgical to endovascular treatment in these locations as well (Table 2).
Discussion
In this large retrospective observational study, involving patients treated for either an unruptured or a ruptured intracranial aneurysm in a large European neurovascular center, we showed that the treatment of intracranial aneurysms shifted rapidly from surgical to endovascular care for all locations, except for the MCA aneurysms. The shift occurred earlier for ruptured than for unruptured aneurysms. The proportion of surgically treated patients decreased from 90 to 20%, with the decrease being most evident for posterior circulation aneurysms, ACOM aneurysms, and ICA aneurysms. At the end of the study period, endovascular treatment had essentially completely replaced surgical treatment for most aneurysms except for MCA aneurysms.
We noticed a general decrease in the number of treated intracranial aneurysms, both ruptured and unruptured. It has been speculated that the incidence of ruptured aneurysms has decreased as a result of successful prophylactic treatment of high-risk unruptured aneurysms [37]; however, it is more likely a consequence of decreased rates of smoking and hypertension [16, 22, 44, 45]. Moreover, the declining treatment rate of unruptured aneurysms is also affected by local policies; for example, treatment is nowadays rarely offered to patients with small aneurysms in locations that rarely rupture (e.g., paraopthalmic aneurysms [19]) or to elderly patients whose treatment-related complication rate surpasses the risks related to the natural history of the aneurysm [21]. Still, given the decreasing number of both the surgical treatment of intracranial aneurysms and the overall incidence, the challenge to maintain a competent surgical neurovascular center increases. Consequently, the European Stroke Organization have recommended the treatment of patients with unruptured intracranial aneurysms to be centralized to centers consulting more than 100 patients per year [11]. Whether this recommendation sufficiently assures high-quality aneurysm treatment, especially surgical treatment, remains unknown.
Our findings align with those of previous studies showing an increase in endovascular treatment over surgical treatment [2, 17, 23, 30, 37, 38]. Notably, the shift in our center occurred almost a decade later than in the USA (2007 vs. 2017) [2, 37]. The main reasons for the later shift can be attributed to the internal strong surgical neurovascular tradition and the need for evidence regarding the safety of endovascular treatment extending beyond a few years of treatment [18, 27, 39]. Still, when the shift took places, it was rapid, happening only over a few years’ time after the change of the chairman of the department in 2015. The swift change of treatment, especially for unruptured ACOM aneurysms, prompted us to oversee treatment results and complications. As could be anticipated, an increase in treatment-related complications of ACOM aneurysms could be seen in the beginning of the treatment shift, after which it decreased notably [12]. However, ACOM is only one of the several locations and similar studies looking at other locations are necessary to back up the shift from endovascular to surgical treatment. In an attempt to monitor the, probably unavoidable, shift towards endovascular treatment also for MCA aneurysms, we have launched a prospective quality of care study, assessing the safety of surgical and endovascular treatment for unruptured intracranial aneurysms (clinicaltrials.gov: NCT06147102).
At the end of our study period, approximately 90% of MCA aneurysms were still clipped. In comparison, approximately 55% of all MCA aneurysms are clipped in the USA [25]. Regionwide data from Europe is not available, but one study from Italy showed that 83% of MCA aneurysms were clipped [40]. One of the main rationales for maintaining surgical expertise for aneurysm clipping is possibility to simultaneously evacuate space-occupying intracerebral hemorrhages (ICH) in case of rupture. Especially for the MCA aneurysms, rupture is associated with a high risk of space-occupying ICHs requiring evacuation [1, 7, 29, 48]. Some authors have argued an endovascular treatment first and hematoma evacuation later approach, which in retrospective have yielded similar results to simultaneous surgical clipping and ICH evacuation [32, 36, 43]. Still, there are some inherited challenges to treat MCA aneurysms endovascularly, as they often are wide-necked and located close to vessel branches (M2 branches or M1 perforants) with poor collateral flow [33, 34]. Consequently, treatment-associated risks are higher and aneurysm occlusion rates are often lower than for other aneurysm locations treated endovascularly [24, 46] or compared to microsurgical clipping [35]. Still, there are studies showing good angiographic results and relatively low risks of complications following endovascular treatment for specific MCA aneurysms [4, 5, 13, 28, 31, 41, 51]. Given the current patient volumes of surgically treated aneurysm patients, even in high-volume neurovascular centers, and the challenges it poses to the training of future neurovascular surgeons, as well as the swift development of endovascular devices, it seems likely that a similar shift for MCA aneurysms will take place.
The use of flow diversion has dramatically changed the treatment of unruptured intracranial aneurysms, especially ICA aneurysms [6, 25]. For example, at the end of our study, over half of all unruptured ICA aneurysms were treated using a flow diverter stent, which is notably more than the 7% in the USA [25]. Of all flow diverters used for unruptured aneurysms in our study, 64% were for the treatment of ICA aneurysms, 15% for ACOM aneurysms, and 13% for VBA aneurysms. Given the continued technology improvement in flow diversion, their usage is likely to continue to increase, which also stresses the need for long-term (> 10 years) follow-up studies to evaluate the long-term effectiveness and safety.
In line with previous studies, our results verify the finding that the majority (57%) of ruptured aneurysms are small (< 7 mm) [19, 42]. However, in contrast to two previous studies conducted in Finland that showed a trend towards decreasing sizes for ruptured aneurysms from 1989–1995 to 2008–2009, we found a trend towards increasing sizes for ruptured aneurysms [19, 20]. The size of the unruptured aneurysms as well as the age of patients treated for an unruptured aneurysm remained stable throughout the study period, indicating that no major changes in the policy of treating unruptured aneurysms changed during the study period (eFigure 6).
Limitations and strengths
We acknowledge some limitations of our study. The retrospective and single-center nature of the study limits its generalizability to other settings. Still, the healthcare system in Finland is publicly funded where all citizens have equal right to healthcare independent of insurance status and the physicians are without from personal incentives to treat patients, increasing the external validity of the study. The long study period (11 years) and manual validation of the data adds strength to the internal validity of the study. Be it noted that our study should not be confounded with a comprehensive epidemiological intracranial aneurysm or SAH study as we did not have data on patients diagnosed with unruptured intracranial aneurysms and who do not undergo treatment, nor on ruptured aneurysms not treated or people dying outside of the hospital. Further, our aim was to report trends in treatment modalities rather than outcomes. Thus, it remains unknown whether the noted shift from surgical to endovascular treatment has affected patient outcome.
Conclusion
A significant shift of treatment from surgical to endovascular treatment occurred for all aneurysm locations except for middle cerebral artery aneurysms. With the decreasing overall incidence of intracranial aneurysms, low-volume centers might expect increasing difficulties to maintain microsurgical expertise of aneurysm treatment. Given the rapid change and relatively low level of long-term evidence the shift is based on, studies assessing long-term safety and patient outcomes should be conducted in the near future.
Data availability
Due to legislative data transfer restrictions imposed by the European Union, the used dataset is not openly available for public use. However, qualified investigators can request access to the data from the Finnish Health and Social Data Permit Authority (findata.fi/en/).
Code availability
Available upon request from the corresponding author.
References
Abbed KM, Ogilvy CS (2003) Intracerebral hematoma from aneurysm rupture. Neurosurg Focus 15(4):1–5
Andaluz N, Zuccarello M (2008) Recent trends in the treatment of cerebral aneurysms: analysis of a nationwide inpatient database. J Neurosurg 108(6):1163–1169
Asikainen A, Korja M, Kaprio J, Rautalin I (2023) Case fatality in patients with aneurysmal subarachnoid hemorrhage in Finland: a nationwide register-based study. Neurology 100(3):e348–e356
Bracard S, Abdel-Kerim A, Thuillier L et al (2010) Endovascular coil occlusion of 152 middle cerebral artery aneurysms: initial and midterm angiographic and clinical results. J Neurosurg 112(4):703–708
Brinjikji W, Lanzino G, Cloft HJ, Rabinstein A, Kallmes DF (2011) Endovascular treatment of middle cerebral artery aneurysms: a systematic review and single-center series. Neurosurgery 68(2):397–402
Chancellor B, Raz E, Shapiro M, Tanweer O, Nossek E, Riina HA, Nelson PK (2020) Flow diversion for intracranial aneurysm treatment: trials involving flow diverters and long-term outcomes. Neurosurgery 86(Supplement_1):S36
Darkwah Oppong M, Skowronek V, Pierscianek D, Gembruch O, Herten A, Saban DV, Dammann P, Forsting M, Sure U, Jabbarli R (2018) Aneurysmal intracerebral hematoma: risk factors and surgical treatment decisions. Clin Neurol Neurosurg 173:1–7
Dott NM (1933) Intracranial aneurysms: cerebral arterio-radiography: surgical treatment *read at a Meeting of the Medico-Chirurgical Society of Edinburgh, on 28th June 1933. Edinb Med J 40(12):T219–T240
Epstein AJ, Polsky D, Yang F, Yang L, Groeneveld PW (2011) Coronary revascularization trends in the United States, 2001–2008. JAMA 305(17):1769–1776
Etminan N, Chang H-S, Hackenberg K, de Rooij NK, Vergouwen MDI, Rinkel GJE, Algra A (2019) Worldwide incidence of aneurysmal subarachnoid hemorrhage according to region, time period, blood pressure, and smoking prevalence in the population: a systematic review and meta-analysis. JAMA Neurol 76(5):588–597
Etminan N, de Sousa DA, Tiseo C et al (2022) European Stroke Organisation (ESO) guidelines on management of unruptured intracranial aneurysms. Eur Stroke J 7(3):V
Haeren R, Hafez A, Korja M, Raj R, Niemelä M (2022) Fast transition from open surgery to endovascular treatment of unruptured anterior communicating artery aneurysms-a retrospective analysis of 128 patients. World Neurosurg 165:e668–e679
Hagen F, Maurer CJ, Berlis A (2019) Endovascular treatment of unruptured MCA bifurcation aneurysms regardless of aneurysm morphology: short- and long-term follow-up. AJNR Am J Neuroradiol 40(3):503–509
Investigators TUJ (2012) The natural course of unruptured cerebral aneurysms in a Japanese cohort. N Engl J Med 366(26):2474–2482
Johnsen L-H, Herder M, Vangberg T, Kloster R, Ingebrigtsen T, Isaksen JG, Mathiesen EB (2022) Prevalence of unruptured intracranial aneurysms: impact of different definitions – the Tromsø Study. J Neurol Neurosurg Psychiat. https://doi.org/10.1136/jnnp-2022-329270
Kastarinen M, Antikainen R, Peltonen M et al (2009) Prevalence, awareness and treatment of hypertension in Finland during 1982–2007. J Hypertens 27(8):1552–1559
Khorasanizadeh M, Pettersson SD, Maglinger B, Garcia A, Wang SJ, Ogilvy CS (2023) Trends in the size of treated unruptured intracranial aneurysms over 35 years. J Neurosurg 139(5):1328–1338
Korja M, Hernesniemi J, Lawton MT, Spetzler RF, Morgan MK (2014) Is cerebrovascular neurosurgery sacrificed on the altar of RCTs? Lancet 384(9937):27–28
Korja M, Kivisaari R, Rezai Jahromi B, Lehto H (2017) Size and location of ruptured intracranial aneurysms: consecutive series of 1993 hospital-admitted patients. J Neurosurg 127(4):748–753
Korja M, Kivisaari R, Rezai Jahromi B, Lehto H (2018) Size of ruptured intracranial aneurysms is decreasing: twenty-year long consecutive series of hospitalized patients. Stroke 49(3):746–749
Korja M, Lehto H, Juvela S (2014) Lifelong rupture risk of intracranial aneurysms depends on risk factors: a prospective Finnish cohort study. Stroke 45(7):1958–1963
Korja M, Lehto H, Juvela S, Kaprio J (2016) Incidence of subarachnoid hemorrhage is decreasing together with decreasing smoking rates. Neurology 87(11):1118–1123
La Pira B, Singh TD, Rabinstein AA, Lanzino G (2018) Time trends in outcomes after aneurysmal subarachnoid hemorrhage over the past 30 years. Mayo Clin Proc 93(12):1786–1793
Link TW, Boddu SR, Hammad HT, Knopman J, Lin N, Gobin P, Patsalides A (2018) Endovascular treatment of middle cerebral artery aneurysms: a single center experience with a focus on thromboembolic complications. Interv Neuroradiol 24(1):14–21
Mirpuri P, Khalid SI, McGuire LS, Alaraj A (2023) Trends in ruptured and unruptured aneurysmal treatment from 2010 to 2020: a focus on flow diversion. World Neurosurg 178:e48–e56
Molyneux A (2002) International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet 360(9342):1267–1274
Molyneux AJ, Birks J, Clarke A, Sneade M, Kerr RSC (2015) The durability of endovascular coiling versus neurosurgical clipping of ruptured cerebral aneurysms: 18 year follow-up of the UK cohort of the International Subarachnoid Aneurysm Trial (ISAT). Lancet 385(9969):691–697
Mortimer AM, Bradley MD, Mews P, Molyneux AJ, Renowden SA (2014) Endovascular treatment of 300 consecutive middle cerebral artery aneurysms: clinical and radiologic outcomes. AJNR Am J Neuroradiol 35(4):706–714
Nemoto M, Masuda H, Sakaeyama Y, Okonogi S, Node Y, Ueda K, Ando S, Kondo K, Harada N, Sugo N (2018) Clinical characteristics of subarachnoid hemorrhage with an intracerebral hematoma and prognostic factors. J Stroke Cerebrovasc Dis 27(5):1160–1166
Pettersson SD, Khorasanizadeh M, Maglinger B, Garcia A, Wang SJ, Taussky P, Ogilvy CS (2023) Trends in the age of patients treated for unruptured intracranial aneurysms from 1990 to 2020. World Neurosurg 178:233-240.e13
Pierot L, Klisch J, Cognard C, Szikora I, Mine B, Kadziolka K, Sychra V, Gubucz I, Januel A-C, Lubicz B (2013) Endovascular WEB flow disruption in middle cerebral artery aneurysms: preliminary feasibility, clinical, and anatomical results in a multicenter study. Neurosurgery 73(1):27–34
de los Reyes K, Patel A, Bederson JB, Frontera JA (2013) Management of subarachnoid hemorrhage with intracerebral hematoma: clipping and clot evacuation versus coil embolization followed by clot evacuation. J Neurointerv Surg 5(2):99–103
Rinne J, Hernesniemi J, Niskanen M, Vapalahti M (1996) Analysis of 561 patients with 690 middle cerebral artery aneurysms: anatomic and clinical features as correlated to management outcome. Neurosurgery 38(1):2–11
Rodríguez-Hernández A, Sughrue ME, Akhavan S, Habdank-Kolaczkowski J, Lawton MT (2013) Current management of middle cerebral artery aneurysms: surgical results with a “clip first” policy. Neurosurgery 72(3):415–427
Rossmann T, Veldeman M, Nurminen V, Huhtakangas J, Niemelä M, Lehecka M (2023) 3D exoscopes are noninferior to operating microscopes in aneurysm surgery: comparative single-surgeon series of 52 consecutive cases. World Neurosurg 170:e200–e213
Salaud C, Hamel O, Riem T, Desal H, Buffenoir K (2016) Management of aneurysmal subarachnoid haemorrhage with intracerebral hematoma: is there an indication for coiling first? Study of 44 cases. Interv Neuroradiol 22(1):5–11
Salem MM, Maragkos GA, Gomez-Paz S, Ascanio LC, Ngo LH, Ogilvy CS, Thomas AJ, Moore JM (2021) Trends of ruptured and unruptured aneurysms treatment in the United States in post-ISAT era: a national inpatient sample analysis. J Am Heart Assoc 10(4):e016998
Samuels OB, Sadan O, Feng C, Martin K, Medani K, Mei Y, Barrow DL (2021) Aneurysmal subarachnoid hemorrhage: trends, outcomes, and predictions from a 15-year perspective of a single neurocritical care unit. Neurosurgery 88(3):574–583
Spetzler RF, McDougall CG, Zabramski JM, Albuquerque FC, Hills NK, Nakaji P, Karis JP, Wallace RC (2019) Ten-year analysis of saccular aneurysms in the Barrow Ruptured Aneurysm Trial. J Neurosurg 132(3):771–776
Sturiale CL, Scerrati A, Ricciardi L et al (2022) Clipping versus coiling for treatment of middle cerebral artery aneurysms: a retrospective Italian multicenter experience. Neurosurg Rev 45(5):3179–3191
Suzuki S, Tateshima S, Jahan R, Duckwiler GR, Murayama Y, Gonzalez NR, Viñuela F (2009) Endovascular treatment of middle cerebral artery aneurysms with detachable coils: angiographic and clinical outcomes in 115 consecutive patients. Neurosurgery 64(5):876–888
Tarkiainen J, Kelahaara M, Pyysalo L, Ronkainen A, Frösen J (2022) Size at which aneurysms rupture: a hospital-based retrospective cohort from 3 decades. Stroke Vasc Interv Neurol 2(4):e000193
Tawk RG, Pandey A, Levy E, Liebman K, Rosenwasser R, Hopkins LN, Veznedaroglu E (2010) Coiling of ruptured aneurysms followed by evacuation of hematoma. World Neurosurg 74(6):626–631
Tuomilehto J, Bonita R, Stewart A, Nissinen A, Salonen JT (1991) Hypertension, cigarette smoking, and the decline in stroke incidence in eastern Finland. Stroke 22(1):7–11
Vartiainen E, Laatikainen T, Peltonen M, Juolevi A, Männistö S, Sundvall J, Jousilahti P, Salomaa V, Valsta L, Puska P (2010) Thirty-five-year trends in cardiovascular risk factors in Finland. Int J Epidemiol 39(2):504–518
Vendrell J-F, Menjot N, Costalat V, Hoa D, Moritz J, Brunel H, Bonafe A (2009) Endovascular treatment of 174 middle cerebral artery aneurysms: clinical outcome and radiologic results at long-term follow-up. Radiology 253(1):191–198
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, STROBE Initiative (2007) Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 335(7624):806–808
Wan A, Jaja BNR, Schweizer TA, Macdonald RL, on behalf of the SAHIT collaboration (2016) Clinical characteristics and outcome of aneurysmal subarachnoid hemorrhage with intracerebral hematoma. J Neurosurg 125(6):1344–1351
Wiebers DO, Whisnant JP, Huston J et al (2003) Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet (London, England) 362(9378):103–110
Yeh RW, Mauri L, Wolf RE, Romm IK, Lovett A, Shahian D, Normand S-L (2015) Population trends in rates of coronary revascularization. JAMA Intern Med 175(3):454–456
Zhang X, Zhou Y, Zuo Q, Duan G, Tang H, Yang P, Xu Y, Hong B, Huang Q, Liu J (2019) Endovascular treatment of ruptured middle cerebral artery aneurysms: a single-arm meta-analysis and systematic review. World Neurosurg 127:559–566
Funding
Open Access funding provided by University of Helsinki (including Helsinki University Central Hospital). The study was funded by research grants from Helsinki University Hospital (TYH2023330), Finska Läkaresällskapet and Svenska Kulturfonden.
Author information
Authors and Affiliations
Contributions
RR and ML designed the study. FC, AMA, AP, AH, and RR contributed to the data collection. RR did the statistical analyses. FC, AMA, and AP wrote the first draft. All authors critically revised the manuscript and approved of final submission. RR, ML, and MN supervised the study.
Corresponding author
Ethics declarations
Ethics approval
Helsinki University Hospital research committee (HUS/313/2022).
Consent to participate
Retrospective study with no need for individual patient consent according to national legislation.
Consent for publication
All authors have read the final version of the manuscript and approved of submission.
Conflict of interest
The authors declare no competing interests.
Disclaimer
The funding agents had no role in study design, data collection, data analysis, data interpretation, or writing of the report.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Below is the link to the electronic supplementary material.
Supplementary file1 eTable 1:
Aneurysm and patient characteristics for surgically treated patients according to surgical technique. (DOCX 15 kb)
Supplementary file2 eTable 2:
Aneurysm and patient characteristics for surgically treated patients according to endovascular technique. (DOCX 16 kb)
Supplementary file3 eFigure 1:
Percentage of aneurysms treated surgically versus endovascularly (upper). Percentage of posterior circulation, middle cerebral artery (MCA) and anterior circulation (not MCA) treated surgically (middle) and endovascularly (lower). (PNG 31.8 mb)
Supplementary file4 eFigure 2:
Median size of all aneurysms treated surgically (left) and endovascularly (right). (PNG 15.0 mb)
Supplementary file5 eFigure 3:
Endovascular treatment technique for unruptured internal carotid artery aneurysms. (PNG 9.16 mb)
Supplementary file6 eFigure 4:
Absolute number of aneurysms treated surgically (left column) and endovascularly (right column) according to aneurysm location. (PNG 56.9 mb)
Supplementary file7 eFigure 5:
Median size of all aneurysms treated surgically and endovascularly (left), of all ruptured aneurysms treated surgically and endovascularly (middle) and of all unruptured aneurysms treated surgically and endovascularly (right). (PNG 22.6 mb)
Supplementary file8 eFigure 6:
Patient age at the time of treatment of a ruptured aneurysm (left) or unruptured aneurysm (right). (PNG 15.1 mb)
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Calvanese, F., Auricchio, A.M., Pohjola, A. et al. Changes in treatment of intracranial aneurysms during the last decade in a large European neurovascular center. Acta Neurochir 166, 173 (2024). https://doi.org/10.1007/s00701-024-06064-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00701-024-06064-4